$Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease$

Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease

Bibliographic Details
Main Authors:	Theodore K. Marras, Mariam Hassan, Kevin C. Mange, Monika Ciesielska, Shilpa Dhar Murthy, Zhanna Jumadilova, Anjan Chatterjee
Format:	Article
Language:	English
Published:	European Respiratory Society 2022-07-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/8/3/00623-2021.full

Similar Items

Amikacin liposome and Mycobacterium avium complex: A systematic review.
by: Moein Zangiabadian, et al.
Published: (2022-01-01)

Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report
by: Hashimoto K, et al.
Published: (2023-10-01)

Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Complex Pulmonary Disease
by: Bo-Guen Kim, et al.
Published: (2024-04-01)

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory <i>Mycobacterium avium</i> Complex Pulmonary Disease
by: Bo-Guen Kim, et al.
Published: (2020-09-01)

Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
by: Seong Min Kim, et al.
Published: (2023-06-01)

The potential role of drug transporters and amikacin modifying enzymes in M. avium
by: Jodie A. Schildkraut, et al.
Published: (2023-09-01)

Rapid differentiation of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis by amplification of insertion element IS901
by: P. Svastova, et al.
Published: (2002-05-01)

Genetic variability of Mycobacterium avium subsp. avium of pig isolates
by: M. Moravkova, et al.
Published: (2007-10-01)

Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence
by: Joy E. Gibson, et al.
Published: (2024-02-01)

DISTRIBUTION OF MYCOBACTERIUM AVIUM COMPLEX IN BULGARIA
by: Yuliana Atanasova, et al.
Published: (2018-12-01)

GENOMICS AND LOCAL ADAPTATION OF MYCOBACTERIUM AVIUM
by: T. Iwamoto
Published: (2018-12-01)

Tuberculosis in cattle caused by IS901+ Mycobacterium avium subsp. avium ? a case report
by: M. Ocepek, et al.
Published: (2003-01-01)

THE IMMUNOPATHOLOGY CAUSED BY ATYPICAL MICOBACTERIA OF MYCOBACTERIUM AVIUM
by: M. M. Averbakh
Published: (2014-07-01)

MYCOBACTERIUM AVIUM AS AN ACTUAL PATHOGEN OF HUMAN MYCOBACTERIOSIS
by: D. A. Starkova
Published: (2014-07-01)

POTENTIAL BACTERICIDAL ACTION OF UHF ON THE STRAINS OF MYCOBACTERIUM AVIUM AND MYCOBACTERIUM TUBERCULOSIS
by: B. L. Ikhlov, et al.
Published: (2019-02-01)

Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease
by: Ping Wang, et al.
Published: (2023-11-01)

Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
by: Ana Motos, et al.
Published: (2023-02-01)

Genotyping of Mycobacterium avium subsp. avium isolates from domestic animals in Slovenia by IS901 RFLP
by: M. Pate, et al.
Published: (2009-06-01)

Simultaneous Detection of Mycobacterium tuberculosis and Mycobacterium avium Complex by a Multiplex PCR
by: Mariana Quaresma de Souza, et al.
Published: (2022-11-01)

Cysteamine/Cystamine Exert Anti-<i>Mycobacterium abscessus</i> Activity Alone or in Combination with Amikacin
by: Ivana Palucci, et al.
Published: (2023-01-01)

Research on Mycobacterium avium during the period 1995 to 2009
by: M. Kaevska, et al.
Published: (2010-10-01)

GENETIC DIVERSITY AND DRUG RESISTANCE OF MYCOBACTERIUM AVIUM IN ITALY
by: f. Genua, et al.
Published: (2018-12-01)

Treatment Outcome in Patients with <i>Mycobacterium abscessus</i> Complex Lung Disease: The Impact of Tigecycline and Amikacin
by: Jeng-How Yang, et al.
Published: (2022-04-01)

Lung tuberculosis in a horse caused by Mycobacterium avium subsp. avium of serotype 2: a case report
by: I. Pavlik, et al.
Published: (2008-02-01)

Sudapyridine (WX-081) antibacterial activity against Mycobacterium avium, Mycobacterium abscessus, and Mycobacterium chelonae in vitro and in vivo
by: Luyao Zheng, et al.
Published: (2024-02-01)

Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis
by: Bubacarr J.B. Touray, et al.
Published: (2023-06-01)

A marmoset model for Mycobacterium avium complex pulmonary disease.
by: Jay Peters, et al.
Published: (2023-01-01)

IMMUNOPATOLOGIYa, OBUSLOVLENNAYa ATIPIChNYMI MIKOBAKTERIYaMI MYCOBACTERIUM AVIUM
by: M. M. Averbakh
Published: (2014-07-01)

Immunological characteristics of cattle with Mycobacterium avium subsp. paratuberculosis infection
by: M. Toman, et al.
Published: (2003-06-01)

THE INFLUENCE OF THE H2 COMPLEX ON MYCOBACTERIUM AVIUM INFECTION IN MICE
by: I. A. Linge, et al.
Published: (2018-12-01)

Clinical Pharmacokinetics of Amikacin in Neonates
by: Gian Maria Pacifici, et al.
Published: (2017-02-01)

Population-Based Distribution of <i>Mycobacterium avium</i> and <i>Mycobacterium intracellulare</i> in Japan
by: Kozo Morimoto, et al.
Published: (2021-09-01)

Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models
by: Luyao Zheng, et al.
Published: (2023-03-01)

Cutaneous mycobacteriosis caused by Mycobacterium avium subspecies avium in a dog: Clinical findings, histopathological and molecular diagnosis and treatment
by: Diba Golchin, et al.
Published: (2024-03-01)

Examination of Mycobacterium avium subsp. avium distribution in naturally infected hens by culture and triplex quantitative real time PCR
by: M. Kaevska, et al.
Published: (2010-07-01)

Treatment of Ventilator-Associated Gram-Negative Pneumonia with Imipenem-Cilastatin/Amikacin Versus Ticarcillin-Clavulanate/Amikacin
by: Ahmet ELALDI, et al.
Published: (2006-06-01)

Scientific justification of Mycobacterium avium survival in natural environment of Republic of Dagestan
by: M. O. Baratov, et al.
Published: (2024-03-01)

Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease
by: Atsuhito Ushiki, et al.
Published: (2024-02-01)

Mycobacterium avium complex pulmonary disease patients with limited treatment options
by: Stefano Aliberti, et al.
Published: (2024-01-01)

Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates
by: Andrea Sanchini, et al.
Published: (2017-01-01)